- Home
- LNTH vs CMA Comparison
LNTH vs CMA Comparison
Compare LNTH & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | CMA |
|---|---|---|
| Founded | 1956 | 1849 |
| Country | United States | United States |
| Employees | N/A | 7928 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 11.5B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | CMA |
|---|---|---|
| Price | $69.61 | $92.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 21 |
| Target Price | ★ $78.00 | $75.10 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 02-25-2026 | 01-23-2026 |
| Dividend Yield | N/A | ★ 3.14% |
| EPS Growth | N/A | ★ 30.50 |
| EPS | 2.39 | ★ 5.23 |
| Revenue | $1,525,933,000.00 | ★ $3,234,000,000.00 |
| Revenue This Year | $0.01 | $6.32 |
| Revenue Next Year | $0.52 | $2.86 |
| P/E Ratio | $28.83 | ★ $17.28 |
| Revenue Growth | 1.95 | ★ 2.31 |
| 52 Week Low | $47.25 | $48.12 |
| 52 Week High | $111.29 | $91.26 |
Technical Indicators
Market Signals| Indicator | LNTH | CMA |
|---|---|---|
| Relative Strength Index (RSI) | 71.09 | 74.50 |
| Support Level | $66.36 | $86.51 |
| Resistance Level | $67.45 | $89.49 |
| Average True Range (ATR) | 1.69 | 1.44 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 93.81 | 95.96 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CMA Comerica Incorporated
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.